Paving the Path to Prevent Peripartum Hysterectomies: Risk Stratification in Placenta Accreta Spectrum

1. Irving FC. The Failure of Placenta to Separate from the Uterine Wall After Delivery. Am J Obstet Gynecol. 1937;38(6): 1088–1200. IrvingFC The Failure of Placenta to Separate from the Uterine Wall After Delivery Am J Obstet Gynecol. 1937 38 6 1088 1200 Search in Google Scholar

2. International Institute for Population Sciences (IIPS) and ICF. National Family Health Survey (NFHS-4), 2015–16: India. Mumbai: IIPS; 2017. International Institute for Population Sciences (IIPS) and ICF National Family Health Survey (NFHS-4), 2015–16: India Mumbai IIPS 2017 Search in Google Scholar

3. Jauniaux E, Ayres-de-Campos D, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction. Int J Gynaecol Obstet. 2018;140(3):261–4. doi: 10.1002/ijgo.12407. JauniauxE Ayres-de-CamposD FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction Int J Gynaecol Obstet. 2018 140 3 261 4 10.1002/ijgo.12407 Open DOISearch in Google Scholar

4. Royal College of Obstetricians and Gynaecologists. Placenta praevia, placenta praevia accreta and vasa praevia: Diagnosis and management. Green-top Guideline No. 27. 2018. Royal College of Obstetricians and Gynaecologists Placenta praevia, placenta praevia accreta and vasa praevia: Diagnosis and management Green-top Guideline No. 27. 2018 Search in Google Scholar

5. American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine. Obstetric care consensus No. 7: Placenta accreta spectrum. Obstetrics and Gynecology. 2018;132: e259–e275. DOI: 10.1097/AOG.0000000000002983. American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine Obstetric care consensus No. 7: Placenta accreta spectrum Obstetrics and Gynecology 2018 132 e259 e275 10.1097/AOG.0000000000002983 Open DOISearch in Google Scholar

6. Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet. 2018;140(3):265–73. JauniauxE ChantraineF SilverRM Langhoff-RoosJ FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology Int J Gynaecol Obstet. 2018 140 3 265 73 Search in Google Scholar

7. Jwa SC, Tamaru S, Takamura M, Namba A, Kajihara T, Ishihara O, Kamei Y. Assisted reproductive technology-associated risk factors for placenta accreta spectrum after vaginal delivery. Sci Rep. 2024 Mar 29;14(1):7454. doi: 10.1038/s41598-024-57988-x. JwaSC TamaruS TakamuraM NambaA KajiharaT IshiharaO KameiY Assisted reproductive technology-associated risk factors for placenta accreta spectrum after vaginal delivery Sci Rep. 2024 Mar 29 14 1 7454 10.1038/s41598-024-57988-x Open DOISearch in Google Scholar

8. International Institute for Population Sciences (IIPS) and ICF. National Family Health Survey (NFHS-5), 2019–21: India. Mumbai: IIPS; 2021. International Institute for Population Sciences (IIPS) and ICF National Family Health Survey (NFHS-5), 2019–21: India Mumbai IIPS 2021 Search in Google Scholar

9. Silver RM, Barbour KD. Placenta accreta spectrum: accreta, increta, and percreta. Obstet Gynecol Clin North Am. 2015;42(3):381–402. SilverRM BarbourKD Placenta accreta spectrum: accreta, increta, and percreta Obstet Gynecol Clin North Am. 2015 42 3 381 402 Search in Google Scholar

10. Bartels HC, Postle JD, Downey P, Brennan DJ. Placenta Accreta Spectrum: A review of pathology, molecular biology, and biomarkers. Dis Markers. 2018 Jul 3;2018:1507674. doi: 10.1155/2018/1507674. BartelsHC PostleJD DowneyP BrennanDJ Placenta Accreta Spectrum: A review of pathology, molecular biology, and biomarkers Dis Markers 2018 Jul 3 2018 1507674 10.1155/2018/1507674 Open DOISearch in Google Scholar

11. Hasegawa J, Furuya N, Doi M, Koike J, Homma C, Nieda M, Nishimura Y, Suzuki N. Histological assessment of the placenta accreta spectrum diagnosed with a 33-MHz linear probe during cesarean Section. Ultrasound Med Biol. 2022 Jun;48(6):1151–6. doi: 10.1016/j.ultrasmedbio.2022.02.010. HasegawaJ FuruyaN DoiM KoikeJ HommaC NiedaM NishimuraY SuzukiN Histological assessment of the placenta accreta spectrum diagnosed with a 33-MHz linear probe during cesarean Section Ultrasound Med Biol. 2022 Jun 48 6 1151 6 10.1016/j.ultrasmedbio.2022.02.010 Open DOISearch in Google Scholar

12. Jauniaux E, Bunce C, Grønbeck L, Langhoff-Roos J. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019 Sep;221(3):208–18. doi: 10.1016/j.ajog.2019.01.233. JauniauxE BunceC GrønbeckL Langhoff-RoosJ Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis Am J Obstet Gynecol 2019 Sep 221 3 208 18 10.1016/j.ajog.2019.01.233 Open DOISearch in Google Scholar

13. Ming Y, Zeng X, Zheng T, Luo Q, Zhang J, Zhang L. Epidemiology of placenta accreta spectrum disorders in Chinese pregnant women: a multicenter hospital-based study. Placenta. 2022 Aug;126:133–9. doi: 10.1016/j.placenta.2022.06.009. MingY ZengX ZhengT LuoQ ZhangJ ZhangL Epidemiology of placenta accreta spectrum disorders in Chinese pregnant women: a multicenter hospital-based study Placenta 2022 Aug 126 133 9 10.1016/j.placenta.2022.06.009 Open DOISearch in Google Scholar

14. El Gelany S, Mosbeh MH, Ibrahim EM, et al. Placenta accreta spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study. BMC Pregnancy Childbirth. 2019;19:313. doi: 10.1186/s12884-019-2466-5. El GelanyS MosbehMH IbrahimEM Placenta accreta spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study BMC Pregnancy Childbirth 2019 19 313 10.1186/s12884-019-2466-5 Open DOISearch in Google Scholar

15. Varlas VN, Bors RG, Birsanu S, Maxim B, Clotea E, Mihailov M. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary centre. J Med Life. 2021;14(3):367–72. VarlasVN BorsRG BirsanuS MaximB CloteaE MihailovM Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary centre J Med Life 2021 14 3 367 72 Search in Google Scholar

16. Adu-Bredu TK, Rijken MJ, Nieto-Calvache AJ, Stefanovic V, Aryananda RA, Fox KA, et al. A simple guide to ultrasound screening for placenta accreta spectrum for improving detection and optimizing management in resource-limited settings. Int J Gynaecol Obstet. 2023 Mar;160(3):732–41. doi: 10.1002/ijgo.14376. Adu-BreduTK RijkenMJ Nieto-CalvacheAJ StefanovicV AryanandaRA FoxKA A simple guide to ultrasound screening for placenta accreta spectrum for improving detection and optimizing management in resource-limited settings Int J Gynaecol Obstet 2023 Mar 160 3 732 41 10.1002/ijgo.14376 Open DOISearch in Google Scholar